Ellodi Pharmaceuticals Welcomes Debra Silberg MD, PhD, FACG to its Board of Directors
LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company, today announced that Evan Dellon M.D, M.P.H, Professor of Gastroenterology at the University of North Carolina at Chapel Hill who served as the Primary Investigator for the Phase 2b study (FLUTE), will present two abstracts during the Digestive Disease Week 2021 virtual meeting on APT-1011 (fluticasone propionate oral disintegrating tablet). Professor Dellon will present one poster of distinction and one oral presentation during the meeting, which is being held from May 21 through May 23, 2021.